Primary intestinal T-cell and natural killer–cell lymphomas: Clinicopathologic and prognostic features of 79 cases in South China
American Journal of Clinical Pathology · 2025
DOI: 10.1093/ajcp/aqae102 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Na Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Cancer Hospital Ringgold, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Intestinal Neoplasms, Lymphoma, Extranodal NK-T-Cell, Lymphoma, T-Cell, Killer Cells, Natural. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, Medical Science and Technology Program of Guangdong Province.
Abstract (Originalsprache)
Objectives
Primary intestinal T-cell and natural killer–cell lymphomas (PITNKLs) are aggressive and make pathologic diagnoses in biopsy specimens challenging. We analyzed different subtypes’ clinicopathologic features and treatment outcomes.
Methods
Seventy-nine PITNKL cases were characterized by clinical, morphologic, and immunohistochemical features.
Results
Among 79 cases of PITNKLs from 2008 to 2017 in our institution, 40 (50.63%) were extranodal NK/T-cell lymphoma, nasal type (ENKTL); 32 (40.51%) monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL); 6 (7.59%) intestinal T-cell lymphoma, not otherwise specified; and 1 (1.27%) indolent T-cell lymphoma of the gastrointestinal tract. Small intestine (n = 47) was the most common site. Monomorphic epitheliotropic intestinal T-cell lymphoma showed distinctive clinicopathologic features from other subtypes with high expression (96.88%) of spleen tyrosine kinase (SYK) and PD-L1 (87.5%) and the poorest prognosis (P < .001). CD30 was highly expressed in ENKTL (9/17, 57.94%) and irrelevant to prognosis (P > .05).
Conclusions
Cases of PITNKL are biologically heterogeneous; most have a dismal prognosis. SYK and PD-L1 expression might be a significant marker for MEITL and helps differential diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Cancer Hospital Ringgold, Hangzhou, Zhejiang, China.
- Chinese Academy of Sciences Ringgold, Beijing, Zhejiang, China.
- Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
- Department of Pathology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
- Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center Ringgold, Guangzhou, Guangdong, China.
Förderung
- Natural Science Foundation of Guangdong Province
- Medical Science and Technology Program of Guangdong Province
Zitieren
APA
Guo, N., Zhou, C., Wang, Y., Fu, J., Chen, Y., Wang, F., & Rao, H. (2025). Primary intestinal T-cell and natural killer–cell lymphomas: Clinicopathologic and prognostic features of 79 cases in South China. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqae102
Vancouver
Guo N, Zhou C, Wang Y, Fu J, Chen Y, Wang F, et al. Primary intestinal T-cell and natural killer–cell lymphomas: Clinicopathologic and prognostic features of 79 cases in South China. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqae102
BibTeX
@article{Guo2025,
author = {Guo, Na and Zhou, Chunlu and Wang, Yu and Fu, Jia and Chen, Yueqiong and Wang, Fang and Rao, Huilan},
title = {Primary intestinal T-cell and natural killer–cell lymphomas: Clinicopathologic and prognostic features of 79 cases in South China},
journal = {American Journal of Clinical Pathology},
year = {2025},
doi = {10.1093/ajcp/aqae102}
}
EUVIMED